CARGO Therapeutics Statistics
Total Valuation
CRGX has a market cap or net worth of $725.99 million. The enterprise value is $377.72 million.
| Market Cap | 725.99M |
| Enterprise Value | 377.72M |
Important Dates
The next estimated earnings date is Wednesday, August 21, 2024, after market close.
| Earnings Date | Aug 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRGX has 45.86 million shares outstanding. The number of shares has increased by 6,770.00% in one year.
| Shares Outstanding | 45.86M |
| Shares Change (YoY) | +6,770.00% |
| Shares Change (QoQ) | +590.31% |
| Owned by Insiders (%) | 7.26% |
| Owned by Institutions (%) | 64.31% |
| Float | 21.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.78, with a Debt / Equity ratio of 0.08.
| Current Ratio | 16.78 |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.04M |
| Employee Count | 116 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 17.75 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.45 |
| Average Volume (20 Days) | 232,415 |
Short Selling Information
The latest short interest is 3.73 million, so 8.14% of the outstanding shares have been sold short.
| Short Interest | 3.73M |
| Short Previous Month | 3.44M |
| Short % of Shares Out | 8.14% |
| Short % of Float | 17.22% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | -121.21M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | -$2.64 |
Balance Sheet
The company has $376.48 million in cash and $28.21 million in debt, giving a net cash position of $348.28 million or $7.59 per share.
| Cash & Cash Equivalents | 376.48M |
| Total Debt | 28.21M |
| Net Cash | 348.28M |
| Net Cash Per Share | $7.59 |
| Equity (Book Value) | 373.21M |
| Book Value Per Share | 8.14 |
| Working Capital | 357.30M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6,770.00% |
| Shareholder Yield | -6,770.00% |
| Earnings Yield | -16.70% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CRGX is $30.83, which is 94.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.83 |
| Price Target Difference | 94.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |